{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:18:12Z","timestamp":1788459492584,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11102-026-01718-1","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:09:14Z","timestamp":1782925754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Etomidate in severe hypercortisolism: early cortisol kinetics and clinical outcomes in a real-world cohort"],"prefix":"10.1007","volume":"29","author":[{"given":"Vivek","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Shaharyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"8","key":"1718_CR1","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO et al (2015) Treatment of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807\u20132831","journal-title":"J Clin Endocrinol Metab"},{"issue":"9996","key":"1718_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015) Cushing\u2019s syndrome. Lancet 386(9996):913\u2013927","journal-title":"Lancet"},{"issue":"3","key":"1718_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/EJE-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"Valassi E, Santos A, Yaneva M, T\u00f3th M, Strasburger CJ, Chanson P et al (2011) The European registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165(3):383\u201392","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1718_CR4","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf039","volume":"9","author":"DT Muthukuda","year":"2025","unstructured":"Muthukuda DT, Liyanaarachchi KD, Jayawickreme KP, Mahesh PKB, Ruwanga VGD, Kumar S et al (2025) Etomidate in severe Cushing syndrome: a systematic review. J Endocr Soc 9(4):bvaf039","journal-title":"J Endocr Soc"},{"issue":"5","key":"1718_CR5","doi-asserted-by":"publisher","first-page":"e2035","DOI":"10.1210\/clinem\/dgab058","volume":"106","author":"MH Schernthaner-Reiter","year":"2021","unstructured":"Schernthaner-Reiter MH, Siess C, Micko A, Zauner C, Wolfsberger S, Scheuba C et al (2021) Acute and life-threatening complications in Cushing syndrome: prevalence, predictors, and mortality. J Clin Endocrinol Metab 106(5):e2035\u2013e2046","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1718_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A (2016) Complications of Cushing\u2019s syndrome: state of the art. Lancet Diabetes Endocrinol 4(7):611\u2013629","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"1718_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1718_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/js.2018-00269","volume":"3","author":"TB Carroll","year":"2019","unstructured":"Carroll TB, Peppard WJ, Herrmann DJ, Javorsky BR, Wang TS, Patel H et al (2019) Continuous etomidate infusion for the management of severe Cushing syndrome: validation of a standard protocol. J Endocr Soc 3(1):1\u201312","journal-title":"J Endocr Soc"},{"issue":"2","key":"1718_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/EJE-12-0274","volume":"167","author":"VA Preda","year":"2012","unstructured":"Preda VA, Sen J, Karavitaki N, Grossman AB (2012) Etomidate in the management of hypercortisolaemia in Cushing\u2019s syndrome: a review. Eur J Endocrinol 167(2):137\u2013143","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1718_CR10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s12020-024-04135-1","volume":"87","author":"L Dzialach","year":"2025","unstructured":"Dzialach L, Sobolewska J, Respondek W, Wojciechowska-Luzniak A, Kuca P, Witek P (2025) Is there still a place for etomidate in the management of Cushing\u2019s syndrome? The experience of a single center of low-dose etomidate and combined etomidate-osilodrostat treatment in severe hypercortisolemia. Endocr Res 87(3):1305\u20131313","journal-title":"Endocr Res"},{"issue":"2","key":"1718_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/EJE-20-0380","volume":"183","author":"SM Constantinescu","year":"2020","unstructured":"Constantinescu SM, Driessens N, Lefebvre A, Furnica RM, Corvilain B, Maiter D (2020) Etomidate infusion at low doses is an effective and safe treatment for severe Cushing\u2019s syndrome outside intensive care. Eur J Endocrinol 183(2):161\u2013167","journal-title":"Eur J Endocrinol"},{"key":"1718_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/2042018819825541","volume":"10","author":"A \u0141ebek-Szata\u0144ska","year":"2019","unstructured":"\u0141ebek-Szata\u0144ska A, Nowak KM, Zgliczy\u0144ski W, Baum E, \u017by\u0142ka A, Papierska L (2019) Low-dose etomidate for the management of severe hypercortisolaemia in different clinical scenarios: a case series and review of the literature. Ther Adv Endocrinol Metab 10:2042018819825541","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1718_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-016-0033-9","volume":"2","author":"D Cuevas-Ramos","year":"2016","unstructured":"Cuevas-Ramos D, Lim DST, Fleseriu M (2016) Update on medical treatment for Cushing\u2019s disease. Clin Diabetes Endocrinol 2:16","journal-title":"Clin Diabetes Endocrinol"},{"key":"1718_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211058583","volume":"13","author":"A Pence","year":"2022","unstructured":"Pence A, McGrath M, Lee SL, Raines DE (2022) Pharmacological management of severe Cushing\u2019s syndrome: the role of etomidate. Ther Adv Endocrinol Metab 13:20420188211058584","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1718_CR15","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaf042","author":"M Araujo-Castro","year":"2026","unstructured":"Araujo-Castro M, Lamas C, Nowak E, Newell-Price J, Reincke M, Castinetti F (2026) Update and practical recommendations for the use of medical treatment of Cushing syndrome. Endocr Rev. https:\/\/doi.org\/10.1210\/endrev\/bnaf042","journal-title":"Endocr Rev"},{"key":"1718_CR16","first-page":"19-0044","volume":"2019","author":"SWP Wong","year":"2019","unstructured":"Wong SWP, Yap YW, Narayanan RP, Al-Jubouri M, Grossman A, Daousi C et al (2019) Etomidate in the management of severe Cushing\u2019s disease and MRSA bacteraemia in a district general hospital in the United Kingdom. Endocrinol Diabetes Metab Case Rep 2019:19\u20130044","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"7","key":"1718_CR17","doi-asserted-by":"publisher","first-page":"e2882","DOI":"10.1210\/clinem\/dgac178","volume":"107","author":"M Gadelha","year":"2022","unstructured":"Gadelha M, Bex M, Feelders RA, Heaney AP, Auchus RJ, Gilis-Januszewska A et al (2022) Randomized trial of osilodrostat for the treatment of Cushing disease. J Clin Endocrinol Metab 107(7):e2882\u2013e2895","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 5","key":"1718_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1258\/acb.2011.011014","volume":"48","author":"PJ Monaghan","year":"2011","unstructured":"Monaghan PJ, Owen LJ, Trainer PJ, Brabant G, Keevil BG, Darby D (2011) Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11\u03b2-hydroxylase inhibitor metyrapone. Ann Clin Biochem 48(Pt 5):441\u2013446","journal-title":"Ann Clin Biochem"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01718-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01718-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01718-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:42:10Z","timestamp":1788457330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01718-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1718"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01718-1","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with institutional ethical standards and the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from participants or waived due to the retrospective design, as per institutional guidelines.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI-assisted language editing tools were used only to improve grammar and readability. All scientific content, data analysis, interpretation, and final manuscript decisions were performed and verified by the authors, who take full responsibility for the integrity and accuracy of the work.","order":4,"name":"Ethics","label":"Use of AI Tools","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"110"}}